Form 4: SI-BONE Director John Freund Receives Equity Grant as Part of Compensation

SI-BONE, Inc. Director John Gordon Freund reported the acquisition of 8,675 shares of common stock through a restricted stock unit grant, vesting upon continued service.

Summary

• John Gordon Freund, a Director of SI-BONE, Inc. (SIBN), reported a change in his beneficial ownership of the company's common stock.
• On June 5, 2025, Mr. Freund acquired 8,675 shares of common stock at a price of $0.00 per share, which represents a grant of restricted stock units (RSUs).
• These RSUs will vest 100% upon the earlier of the next annual general meeting of stockholders or one year from the Vesting Commencement Date, contingent on Mr. Freund's continuous service on the Board of Directors.
• Following this transaction, Mr. Freund directly beneficially owns 43,301 shares of common stock, which includes the 8,675 shares issuable from the newly granted RSUs.
• Additionally, Mr. Freund indirectly beneficially owns 103,899 shares through John Freund Family Partners IV, LP, where he is a general partner, though he disclaims beneficial ownership beyond his pecuniary interest.

Sentiment

Score: 6

Explanation: The sentiment is slightly positive as it reflects a routine equity compensation grant to a director, aligning management's interests with shareholders. It's not highly impactful but indicates ongoing commitment.

Positives

• The grant of restricted stock units aligns the director's interests with those of shareholders, as the value of the compensation is tied to the company's stock performance.
• The vesting schedule encourages continued service and commitment from a key board member.

Negatives

• The issuance of new shares upon RSU vesting could lead to minor dilution for existing shareholders, though this is a standard form of equity compensation.

Risks

• The vesting of the restricted stock units is contingent on John Freund's continuous service as a director; if his service ceases before vesting, the shares may be forfeited.

Future Outlook

The restricted stock units granted to Director John Freund are set to vest 100% upon the earlier of the next annual general meeting of stockholders or one year from the Vesting Commencement Date, provided his continuous service on the Board of Directors.

Industry Context

This Form 4 filing is a routine disclosure of insider stock ownership changes, common across all publicly traded companies, and does not provide specific industry-related insights beyond the company's name, SI-BONE, Inc., which operates in the medical device or healthcare sector.

Corporate Governance

Related Party Transactions

• John Freund indirectly beneficially owns 103,899 shares through John Freund Family Partners IV, L.P., where he serves as a general partner. He disclaims beneficial ownership except for his pecuniary interest.

Stakeholder Impact

• Shareholders: Minor potential for dilution upon RSU vesting, but this is a standard practice for director compensation.
• Director (John Freund): Receives equity compensation, aligning his financial interests with the company's performance.

Next Steps

• Vesting of the 8,675 restricted stock units upon the earlier of the next annual general meeting or one year from the Vesting Commencement Date, subject to continuous service.

Key Dates

Recommendation

Keywords

SI-BONE, SIBN, Form 4, Insider Trading, Beneficial Ownership, Restricted Stock Units, RSU, Director Compensation, Equity Grant, Corporate Governance